Our development, discovery and product pipelines
Disclaimer: These pipelines are as planned or envisaged as of August 2025. Projects and products indicated on this page may in the future be amended or abandoned , and additional projects may be added.
Development pipeline
These are our products under development with therapeutic potential based on scientific rationales. They are based on our patented (granted, pending or in progress) discoveries already enabled by our rapid AI guided discovery platform.
They are currently at pre-clinical stage from a drug-regulation aspect. They have been validated as indicated, including in animal models or in non-pharmaceutical clinical evaluation in humans, i.e., as cosmetic or food supplement.
Some of these products may directly undergo a traditional clinical pharmaceutical path development (Phase I,II,III) with a pharmaceutical partner. Some of these products may be initially made available as cosmetics or food supplements without medical claims and undergo non-pharmaceutical clinical evaluation. Should significant therapeutic benefits be observed, they may eventually be further developed as fully fledged registered pharmaceuticals.
WECMEP™ = Water Extract of Complex Mix of Edible Plants
FASBAM™ = Fragrance and Aroma Synergistic BioActive Mixes. NB: these are chemically defined compositions.
NUTRES™ = NUtritional Therapeutic Response Enhancement Solutions
Mokaskin®, Synherbs®, EFFIRECsa™ and EFFIRECsa™ are product line trade names.
Discovery pipeline
These are our AI guided discovery efforts we are conducting with academic (later also industrial) partners thanks to our AI guided rapid discovery discovery platform. These discoveries are expected to generate novel IP/patents owned or co-owned by Alphanosos.
They are deemed to be initially made available as food supplements without medical claims and undergo non-pharmaceutical clinical evaluation. Should significant therapeutic benefits being observed, and following market, usages and regulatory considerations, they may eventually be further (also) developed as fully fledged registered pharmaceuticals.
WECMEP™ = Water Extract of Complex Mix of Edible Plants
Product pipeline
These are finished products in development that will be marketed by us on our e-commerce sites and by commercial partners and distributors. Here we indicate product trade names as used by us.
They are based on our patented (granted, pending or in progress) discoveries already enabled by our rapid AI guided discovery platform.
Their therapeutic potential is based on scientific rationales. It is planned to have them undergo non-pharmaceutical clinical evaluation. Nevertheless, due to market, usages and regulatory considerations, they are deemed to be made available solely as cosmetics or food supplements without medical claims.
dbap = double blinded against placebo
